Number of Californians living with Alzheimer’s projected to double by 2040
The number of Californians 65 and older living with Alzheimer’s disease is projected to more than double by the year 2040, according to new data released by the California Department of Public Health in conjunction with the Alzheimer’s Association.
More questions for J&J vaccine boosters ahead of FDA review
The Food and Drug Administration is wrestling with whether and when to offer another dose of the single-shot Johnson & Johnson COVID-19 vaccine, while a new study out Wednesday raises the prospect that using a different brand as the booster might work better.
Exposure to Childhood Adversity Linked to Early Mortality; Nearly Half a Million Annual U.S. Deaths
The findings of a new study suggest that childhood adversity is a major contributor to early and preventable causes of mortality and a powerful determinant of long-term physical and mental health. Researchers at Columbia University Mailman School of Public Health and Harvard University found that childhood adversity is associated with elevated risk for chronic disease, including heart disease and cancer.
FDA authorizes first e-cigarette, cites benefit for smokers
For the first time, the Food and Drug Administration on Tuesday authorized an electronic cigarette, saying the vaping device from R.J. Reynolds can help smokers cut back on conventional cigarettes.
CMS Releases 2022 Medicare Advantage and Part D Star Ratings to Help Medicare Beneficiaries Compare Plans
The Centers for Medicare & Medicaid Services (CMS) released the 2022 Star Ratings for Medicare Advantage (Medicare Part C) and Medicare Part D prescription drug plans to help people with Medicare compare plans ahead of Medicare Open Enrollment, which kicks off on October 15. Plans are rated on a one-to-five scale, with one star representing poor performance and five stars representing excellent performance.
